Biography
Dr Stephen Ahenkorah holds PhD in Biomedical Sciences (Radiopharmacy) and currently works as an associate research scientist at the radiology department of the University of Iowa. Prior to this position he was a postdoctoral fellow at KU Leuven, Belgium where he developed an agent called 3p-C-NETA-TATE for targeting neuroendocrine tumors in vivo.
Research Interest
Development of radiopharmaceuticals for cancer treatment
Contribution by Topic Area
Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
Research Articles
- Unraveling Cognitive Aging: A Comprehensive Narrative Review of the Seattle Longitudinal Study and Recent Breakthroughs
- Contamination in Heat Exchangers: Types, Energy Effects and Prevention Methods
- The Impact of Stress on Periodontal Health: A Biomarker-Based Review of Current Evidence
- Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis
- Enhancing Material Property Predictions through Optimized KNN Imputation and Deep Neural Network Modeling
- Development of a Mechanical Seal Closed Design Model
Advertisement